pillbase.ru

Denosumab-BMWO

Active substance: denosumab

INJECTION · DENOSUMAB 120 mg/1.7mL

United StatesActive

Marketing holder: CELLTRION USA, Inc.

Verified 2026-10-09 · openFDA NDC

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
EU 32
  • Acvybra
    denosumab
    EMEA/H/C/006734
    Reddy Holding GmbH
  • Bildyos
    denosumab
    EMEA/H/C/006434
    Sciencepharma Sp. z o.o
  • Bilprevda
    denosumab
    EMEA/H/C/006435
    Sciencepharma Sp. z o.o
  • Bomyntra
    denosumab
    EMEA/H/C/006269
    Fresenius Kabi Deutschland GmbH
  • Conexxence
    denosumab
    EMEA/H/C/006268
    Fresenius Kabi Deutschland GmbH
All products in this country (32)
Import and control

Control by country

  • United Statesprescription only

    Source: openFDA NDC · record 01a1208c-af15-7660-a5b9-6bad6d75c5a9,01a1208c-cc99-751b-83cd-3fa4af4bb00e,01a1208d-a0b0-701a-a83c-11364a6aa720,01a1208f-1c05-77b7-a323-bed2378ccf67,01a1208f-405a-7d42-ad99-998889011fa0;count=22 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
72606-059
Registration status
Active
Dispensing
Prescription only
Route
SUBCUTANEOUS
Sources
  • product · openFDA NDC · 72606-059 · Verified 2026-10-09 · open in source
  • registration_status · openFDA NDC · 72606-059 · Verified 2026-10-09 · open in source
  • ingredients.0 · openFDA NDC · 72606-059 · Verified 2026-10-09 · open in source